Murata T, Akagi K, Imamura M, Nasu R, Kimura H, Nagata K, Tanaka Y
Department of Radiology, Kansai Medical University, 10-15 Fumizonochou, Moriguchi City, Osaka, 570, Japan.
Oncol Rep. 1998 May-Jun;5(3):709-12. doi: 10.3892/or.5.3.709.
Arterial chemoembolization using degradable starch microspheres and adriamycin was combined with hyperthermia to treat advanced liver cancer. The prolonged peak adriamycin level in hepatic venous blood suggested that the drug persisted for longer in the liver after injection containing microspheres. Heating efficiency was increased more in tumor tissue than in normal liver tissue after embolization. This combined therapy was performed in eight patients with advanced liver cancer and was effective in three (complete or partial remission). The mean survival time was 25 weeks and there were no severe side effects. This combined therapy may be useful for liver cancer.
使用可降解淀粉微球和阿霉素进行动脉化疗栓塞,并结合热疗来治疗晚期肝癌。肝静脉血中阿霉素峰值水平的延长表明,在注射含微球的药物后,药物在肝脏中持续的时间更长。栓塞后肿瘤组织的加热效率比正常肝组织增加得更多。该联合疗法应用于8例晚期肝癌患者,3例有效(完全或部分缓解)。平均生存时间为25周,且无严重副作用。这种联合疗法可能对肝癌有用。